间皮瘤:预防、诊断与治疗的科学线索
间皮瘤主要影响曾职业暴露于石棉的老年人群,全球发病与死亡数据因发展中国家数据缺失而不明。在1970–1980年代禁用或严格管制石棉的国家,发病率已下降但死亡总数未减。新型免疫组化与分子标志物提高了诊断准确性,但误诊率仍达14%(高资源国家)至50%(发展中国家)。
要点
- 石棉禁用或严格管制后间皮瘤发病率下降,但老龄化使死亡总数未减。
- 环境致癌纤维扰动可形成间皮瘤热点区域。
- 误诊率在高资源国家约14%、发展中国家达50%。
核心结论
- 石棉暴露是间皮瘤主要病因,预防措施可降低发病率但死亡总数受人口老龄化影响未减。
- 诊断准确性仍不足,误诊率在高资源国家约14%、发展中国家达50%,影响治疗与流行病学研究。
- BAP1癌症综合征揭示了部分致病机制,针对分子机制和免疫调节的治疗正在测试中。
- 腹膜间皮瘤的治疗结局正在改善,而胸膜间皮瘤手术作用仍有争议。
研究设计与样本
- 本文为CA Cancer J Clin发表的综述,汇总间皮瘤预防、诊断与治疗的科学线索。
主要发现
- 在1970–1980年代禁用或严格管制石棉的澳大利亚、美国、西欧,间皮瘤发病率已下降。
- 上述国家间皮瘤死亡总数未下降,因人口规模增大和老年人口比例增加。
- 农村地区开发扰动环境中的致癌纤维时,可能出现间皮瘤热点。
- 新型免疫组化和分子标志物提高了诊断准确性,但误诊率仍为14%(高资源国家)至50%(发展中国家)。
- 生殖系BAP1突变可导致间皮瘤和其他癌症(BAP1癌症综合征),相关分子靶向和免疫调节治疗正在测试。
关键数值与推荐
- 间皮瘤误诊率:高资源国家约14%,发展中国家约50%。
临床怎么用
- 应重视石棉职业暴露史的采集,尤其在老年间皮瘤患者中。
- 在石棉禁用或严格管制地区,间皮瘤发病率下降提示预防措施有效,应持续执行。
- 诊断时应结合新型免疫组化和分子标志物以提高准确性,减少误诊。
- 对疑似BAP1癌症综合征患者考虑生殖系BAP1突变检测。
- 胸膜间皮瘤手术获益难以预测,需多学科评估;腹膜间皮瘤治疗结局正在改善。
局限性
- 全球间皮瘤发病与死亡数据未知,因发展中国家数据不可得。
- 胸膜间皮瘤手术作用存在争议,难以预测哪些患者从积极治疗中获益。
- 误诊率高(高资源国家约14%、发展中国家约50%)使流行病学研究复杂化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mesothelioma affects mostly older individuals who have been occupationally exposed to asbestos. The global mesothelioma incidence and mortality rates are unknown, because data are not available from developing countries that continue to use large amounts of asbestos. The incidence rate of mesothelioma has decreased in Australia, the United States, and Western Europe, where the use of asbestos was banned or strictly regulated in the 1970s and 1980s, demonstrating the value of these preventive measures. However, in these same countries, the overall number of deaths from mesothelioma has not decreased as the size of the population and the percentage of old people have increased. Moreover, hotspots of mesothelioma may occur when carcinogenic fibers that are present in the environment are disturbed as rural areas are being developed. Novel immunohistochemical and molecular markers have improved the accuracy of diagnosis; however, about 14% (high-resource countries) to 50% (developing countries) of mesothelioma diagnoses are incorrect, resulting in inadequate treatment and complicating epidemiological studies. The discovery that germline BRCA1-asssociated protein 1 (BAP1) mutations cause mesothelioma and other cancers (BAP1 cancer syndrome) elucidated some of the key pathogenic mechanisms, and treatments targeting these molecular mechanisms and/or modulating the immune response are being tested. The role of surgery in pleural mesothelioma is controversial as it is difficult to predict who will benefit from aggressive management, even when local therapies are added to existing or novel systemic treatments. Treatment outcomes are improving, however, for peritoneal mesothelioma. Multidisciplinary international collaboration will be necessary to improve prevention, early detection, and treatment.
引用
- Carbone M, Adusumilli PS, Alexander HR, et al. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 2019. PMID: 31283845. doi:10.3322/caac.21572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。